论文部分内容阅读
目的:评价慢性阻塞性肺疾病急性加重期中西医结合临床路径实施效果。方法:采用历史对照研究,比较实施临床路径前(传统组)与实施临床路径后(路径组)慢性阻塞性肺疾病患者的住院时间、住院费用、治疗效果(住院病死率及并发症发生率、呼吸困难分级及临床症状积分)、病人满意度。结果:与传统组比较,路径组的住院时间、住院总费用、住院平均日费用及单项费用均有明显下降(P<0.01),同期临床症状改善(P<0.05),但病死率、并发症发生率及病人满意度经检验无统计学意义(P>0.05)。结论:慢性阻塞性肺疾病急性加重期实施中西医结合临床路径,在确保疗效的同时可减轻病人的医疗负担、充分利用医疗资源,值得推广应用。
Objective: To evaluate the clinical effect of integrated traditional Chinese and western medicine on acute exacerbation of chronic obstructive pulmonary disease. Methods: The historical control study was conducted to compare the length of hospital stay, hospitalization expenses, treatment effect (hospital mortality and complication rate, hospitalization rate, Dyspnea classification and clinical symptom scores), patient satisfaction. Results: Compared with the traditional group, the hospitalization time, the total cost of hospitalization, the average hospitalization cost and the individual expense of the pathological group decreased significantly (P <0.01), and the clinical symptoms improved over the same period (P <0.05), but the mortality, complications The incidence and patient satisfaction had no statistical significance (P> 0.05). Conclusion: The clinical path of integrated traditional Chinese and Western medicine in acute exacerbation of chronic obstructive pulmonary disease can reduce the medical burden of patients and make full use of medical resources, which is worth popularizing and applying.